IgG4-related Sclerosing Cholangitis With and Without Hepatic Inflammatory Pseudotumor, and Sclerosing Pancreatitis-associated Sclerosing Cholangitis: Do They Belong to a Spectrum of Sclerosing Pancreatitis?

Sclerosing cholangitis (SC) is a heterogeneous disease entity. Different etiologies such as choledocholithiasis, biliary tumor, or pericholangitis can manifest as SC. Hepatic inflammatory pseudotumor (IP) is rarely associated with SC (sclerosing cholangitis associated with hepatic inflammatory pseudotumor; SC-hepatic IP), but sclerosing pancreatitis (SP) is not infrequently associated with bile duct lesions (sclerosing pancreatitis-associated sclerosing cholangitis; SP-SC). In this study, we compared the histologic changes of hepatic hilar and extrahepatic bile duct lesions of SC (7 cases), SC-hepatic IP (5 cases), SP-SC (5 cases), and typical primary sclerosing cholangitis (PSC) (5 cases). Histologically, all SP-SC cases showed extensive and dense fibrosis with marked lymphoplasmacytic infiltration, many eosinophils, and obliterative phlebitis. Four cases of SC showed bile duct lesions similar to those of SP-SC, whereas other three cases of SC showed milder lymphoplasmacytic infiltration, scant eosinophilic cell infiltration, and no obliterative phlebitis. All SC-hepatic IP cases showed bile duct lesions identical to those of SP-SC. Immunohistochemically, many IgG4-positive plasma cells were found in the bile duct lesions of all SP-SC cases, 4 SC cases with marked lymphoplasmacytic infiltration, and all SC-hepatic IP cases. By contrast, IgG4-positive plasma cells were scarce or hardly found in the remaining 3 SC cases and all PSC cases. In conclusion, 4 SC cases and all SC-hepatic IP cases showed bile duct lesions identical to those of SP-SC, suggesting that these three conditions may be a single disease entity. Their pathogenesis may be similar or closely related to that of SP, and in that respect they may represent an IgG4-related biliary disease. They may respond to steroid therapy as SP does.

[1]  T. Terada,et al.  Glandular elements around the intrahepatic bile ducts in man; their morphology and distribution in normal livers. , 2008, Liver.

[2]  Myung-Hwan Kim,et al.  Autoimmune pancreatitis: it may be a worldwide entity. , 2004, Gastroenterology.

[3]  M. N. Toosi,et al.  Pancreatic Pseudotumor with Sclerosing Pancreato-Cholangitis: Is This a Systemic Disease? , 2004, American Journal of Gastroenterology.

[4]  Y. Shiratori,et al.  Involvement of the biliary system in autoimmune pancreatitis: a follow-up study. , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[5]  S. Ikeda,et al.  A primary Sjögren's syndrome patient with marked swelling of multiple exocrine glands and sclerosing pancreatitis. , 2002, Internal medicine.

[6]  K. Okazaki.  Clinical relevance of autoimmune-related pancreatitis. , 2002, Best practice & research. Clinical gastroenterology.

[7]  A. Oto,et al.  Multifocal fibrosclerosis: a new case report and review of the literature , 2002, European Radiology.

[8]  S. Kawa,et al.  Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis , 2002, The Lancet.

[9]  Philip R. Cohen,et al.  Lymphoplasmacytic sclerosing pancreatitis and cholangitis. , 2002, Gastrointestinal endoscopy.

[10]  K. Okazaki,et al.  Autoimmune-related pancreatitis , 2001, Current treatment options in gastroenterology.

[11]  M. Tsou,et al.  Inflammatory Pseudotumor-Like Follicular Dendritic Cell Tumor: A Distinctive Low-Grade Malignant Intra-abdominal Neoplasm With Consistent Epstein–Barr Virus Association , 2001, The American journal of surgical pathology.

[12]  S. Kawa,et al.  Sclerosing pancreato-cholangitis responsive to corticosteroid therapy: report of 2 case reports and review. , 2001, Gastrointestinal endoscopy.

[13]  M. Türkmen,et al.  Inflammatory pseudotumor of the spleen , 2001, Virchows Archiv.

[14]  T. Nikaido,et al.  High serum IgG4 concentrations in patients with sclerosing pancreatitis. , 2001, The New England journal of medicine.

[15]  C. Benz,et al.  [Primary sclerosing cholangitis]. , 2000, Der Internist.

[16]  I. Yasuda,et al.  Inflammatory pseudotumor of the liver with primary sclerosing cholangitis , 2000, Journal of Gastroenterology.

[17]  G. Erkelens,et al.  Sclerosing pancreato-cholangitis responsive to steroid therapy , 1999, The Lancet.

[18]  M. Loda,et al.  Nodular lymphoid lesion of the liver: an immune-mediated disorder mimicking low-grade malignant lymphoma. , 1999, The American journal of surgical pathology.

[19]  Y. Nakanuma,et al.  Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply , 1997, Microscopy research and technique.

[20]  P. Telesinghe,et al.  Inflammatory pseudotumour of the liver. , 1997, Journal of clinical pathology.

[21]  I. Ng,et al.  Follicular dendritic cell tumor of the liver. Evidence for an Epstein-Barr virus-related clonal proliferation of follicular dendritic cells. , 1996, The American journal of surgical pathology.

[22]  K. Shiratori,et al.  Chronic pancreatitis caused by an autoimmune abnormality , 1995, Digestive Diseases and Sciences.

[23]  J. Boyer,et al.  Pseudotumor of the pancreas associated with retroperitoneal fibrosis: a dramatic response to corticosteroid therapy. , 1995, The American journal of gastroenterology.

[24]  Y. L. Le Treut,et al.  Inflammatory pseudotumour of the liver. , 1995, The European journal of surgery = Acta chirurgica.

[25]  P. Anthony.  Inflammatory pseudotumour (plasma cell granuloma) of lung, liver and other organs , 1993, Histopathology.

[26]  R. Aalberse,et al.  Allergen‐specific IgG4 in atopic disease , 1993, Allergy.

[27]  K. Chan,et al.  Inflammatory Pseudotumor of the Liver: Report of Four Cases and Review of the Literature , 1993 .

[28]  E. Ottesen,et al.  Control of allergic reactivity in human filariasis. Predominant localization of blocking antibody to the IgG4 subclass. , 1992, Journal of immunology.

[29]  Kenji Kawaguchi,et al.  Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. , 1991, Human pathology.

[30]  K. Sayama,et al.  Subclass Characteristics of IgG Autoantibodies in Bullous Pemphigoid and Pemphigus , 1990, The Journal of dermatology.

[31]  T. Terada,et al.  Pathologic features of hepatolithiasis in Japan. , 1988, Human pathology.

[32]  R. Wiesner,et al.  Current concepts in primary sclerosing cholangitis. , 1984, Mayo Clinic proceedings.

[33]  R. Bree,et al.  Inflammatory pseudotumor from sclerosing cholangitis. , 1983, Journal of computer assisted tomography.

[34]  J. H. Cooper,et al.  Primary sclerosing cholangitis. Complete gross and histologic reversal after long-term steroid therapy. , 1970, The American journal of gastroenterology.

[35]  W. Ewig.  [Diseases of the bile ducts]. , 1961, Hippokrates.

[36]  H. Takikawa,et al.  Primary sclerosing cholangitis in Japan—analysis of 192 cases , 2005, Journal of Gastroenterology.

[37]  O. Matsui,et al.  Hepatic hilar inflammatory pseudotumor mimicking cholangiocarcinoma with cholangitis and phlebitis--a variant of primary sclerosing cholangitis? , 1997, Pathology, research and practice.

[38]  K. Tsuneyama,et al.  Hepatic inflammatory pseudotumor associated with chronic cholangitis: report of three cases. , 1994, Human pathology.

[39]  J. Ludwig.  Surgical pathology of the syndrome of primary sclerosing cholangitis. , 1989, The American journal of surgical pathology.

[40]  R. Aalberse,et al.  Immunochemical characteristics of IgG4 antibodies. , 1988, New England and regional allergy proceedings.